4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000019
$BHCCIK 0000885590operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:24 PM ET
Size
13.7 KB
Accession
0000885590-15-000019
Insider Transaction Report
Form 4
Chai-Onn Robert Roswell
EVP, GC & Corp. Sec.
Transactions
- Exercise/Conversion
Common Stock, no par value
2015-03-02$25.42/sh+90,939$2,311,669→ 112,296 total - Exercise/Conversion
Non-Qualified Stock Options (right to purchase)
2015-03-03−21,808→ 21,807 totalExercise: $6.10From: 2009-11-01Exp: 2015-11-01→ Common shares, no par value (21,808 underlying) - Sale
Common Stock, no par value
2015-03-02$200.01/sh−90,939$18,189,091→ 21,379 total - Exercise/Conversion
Common Stock, no par value
2015-03-03$6.10/sh+21,808$133,029→ 43,187 total - Exercise/Conversion
Non-Qualified Stock Options (right to purchase)
2015-03-02−90,939→ 90,938 totalExercise: $25.42From: 2014-10-08Exp: 2015-11-11→ Common shares, no par value (90,939 underlying)
Footnotes (4)
- [F1]This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 11, 2015.
- [F2]This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold, in each case pursuant to a 10b5-1 trading plan. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- [F3]This number represents options exercised and held pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 1, 2015.
- [F4]The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the vesting commencement date, the second vest date falling on the second anniversary of the vesting commencement date, the third vest date falling on the third anniversary of the vesting commencement date, and the fourth vest date falling on the fourth anniversary of the vesting commencement date.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:24 PM ET
- Size
- 13.7 KB